Preventative Maintenance of Above Standard Equipment (ASE) � FDA White Oak Campus
- Response deadline
- Jul 31, 2026 Due in 13 days
- Date posted
- Jul 16, 2026
- Source
- Open notice
Description
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing this Request for Information (RFI) for market research purposes only. This notice is not a solicitation, Request for Quotation (RFQ), or Request for Proposal (RFP), and does not obligate the Government to award a contract. The FDA is seeking information from interested and capable vendors regarding the establishment of a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract to provide Above Standard Equipment (ASE) maintenance and related services for laboratory, scientific, and research equipment located primarily at the FDA White Oak Campus and other FDA facilities as identified in future task orders. The attached RFI provides a description of the anticipated requirement, requested vendor information, and submission instructions. Interested parties are encouraged to review the attachment in its entirety and submit responses in accordance with the instructions provided. Responses will be used solely for acquisition planning and market research. The Government will not reimburse respondents for any costs associated with preparing or submitting a response to this notice.
Classifications
Documents (7)
- DRAFT Attachment III - Task Order 2 Statement of Work.pdf.pdf352 KBNot yet available
- DRAFT_Attachment I - Above Standard Equipment IDIQ Statement of Work.pdf.pdf433 KBNot yet available
- DRAFT Attachment IV - Task Order 3 Statement of Work - After Hours.pdf.pdf283 KBNot yet available
- IDIQ Attachment 1 - Site List.xlsx.xlsx25 KBNot yet available
- RFI_FINAL_OC-2027-132720.pdf.pdf242 KBNot yet available
- DRAFT Attachment V - Task Order 4 Statement of Work - Site Scan.pdf.pdf301 KBNot yet available
- DRAFT Attachment II - Task Order 1 Statement of Work.pdf.pdf410 KBNot yet available
Contacts
- L. Maria Finanlinda.finan@fda.hhs.gov2404025712
- Iris Johnsoniris.johnson1@fda.hhs.gov3017963353